Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
89.01
-0.59 (-0.66%)
Aug 5, 2026, 4:00 PM EDT - Market closed
Edwards Lifesciences Employees
Edwards Lifesciences had 16,000 employees as of December 31, 2025. The number of employees increased by 200 or 1.27% compared to the previous year.
Employees
16,000
Change (1Y)
200
Growth (1Y)
1.27%
Revenue / Employee
$407,019
Profits / Employee
$62,806
Market Cap
51.21B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 16,000 | 200 | 1.27% |
| Dec 31, 2024 | 15,800 | -4,000 | -20.20% |
| Dec 31, 2023 | 19,800 | 2,500 | 14.45% |
| Dec 31, 2022 | 17,300 | 1,600 | 10.19% |
| Dec 31, 2021 | 15,700 | 800 | 5.37% |
| Dec 31, 2020 | 14,900 | 1,000 | 7.19% |
| Dec 31, 2019 | 13,900 | 1,100 | 8.59% |
| Dec 31, 2018 | 12,800 | 600 | 4.92% |
| Dec 31, 2017 | 12,200 | 1,100 | 9.91% |
| Dec 31, 2016 | 11,100 | 1,300 | 13.27% |
| Dec 31, 2015 | 9,800 | 700 | 7.69% |
| Dec 31, 2014 | 9,100 | 500 | 5.81% |
| Dec 31, 2013 | 8,600 | 400 | 4.88% |
| Dec 31, 2012 | 8,200 | 400 | 5.13% |
| Dec 31, 2011 | 7,800 | 800 | 11.43% |
| Dec 31, 2010 | 7,000 | 600 | 9.38% |
| Dec 31, 2009 | 6,400 | 200 | 3.23% |
| Dec 31, 2008 | 6,200 | 600 | 10.71% |
| Dec 31, 2007 | 5,600 | 50 | 0.90% |
| Dec 31, 2006 | 5,550 | 150 | 2.78% |
| Dec 31, 2005 | 5,400 | 200 | 3.85% |
| Dec 31, 2004 | 5,200 | 200 | 4.00% |
| Dec 31, 2003 | 5,000 | 0 | - |
| Dec 31, 2002 | 5,000 | 189 | 3.93% |
| Dec 31, 2001 | 4,811 | -289 | -5.67% |
| Dec 31, 2000 | 5,100 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Abbott Laboratories | 115,000 |
| Medtronic | 95,000 |
| Koninklijke Philips | 65,340 |
| Boston Scientific | 59,000 |
| Stryker | 56,000 |
| GE HealthCare Technologies | 54,000 |
| STERIS | 17,937 |
| Zimmer Biomet Holdings | 17,000 |
EW News
- 8 days ago - Edwards Lifesciences upgraded to Buy from Neutral at UBS - TheFly
- 12 days ago - Edwards Lifesciences price target raised to $105 from $100 at JPMorgan - TheFly
- 12 days ago - Leerink upgrades Edwards Lifesciences to Outperform, raises target to $101 - TheFly
- 12 days ago - Edwards Lifesciences price target raised to $101 from $100 at Piper Sandler - TheFly
- 12 days ago - Edwards Lifesciences upgraded to Outperform from Market Perform at Leerink - TheFly
- 12 days ago - Edwards Lifesciences beats quarterly estimates on strong demand for heart devices - Reuters
- 12 days ago - Edwards Lifesciences Narrows Full-Year Sales Outlook After Second-Quarter Growth - WSJ
- 12 days ago - Edwards Lifesciences Earnings Call Transcript: Q2 2026 - Transcripts